home / stock / allo / allo news


ALLO News and Press, Allogene Therapeutics Inc. From 05/13/24

Stock Information

Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com

Menu

ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...

ALLO - Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the pricing of an underwr...

ALLO - Allogene Therapeutics GAAP EPS of -$0.38 beats by $0.03

2024-05-13 16:09:59 ET More on Allogene Therapeutics Allogene Therapeutics: 2024 Platform Vision Sings Mid-Term Upside Allogene Therapeutics, Inc. (ALLO) Q4 2023 Earnings Call Transcript Allogene Therapeutics Q1 2024 Earnings Preview Allogene Therapeutics GAA...

ALLO - Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update

Cemacabtagene Ansegedleucel (Cema-Cel) Expanded CD19 Oncology Rights to Include all EU Member States and the United Kingdom, Reinforcing Company’s Conviction in the Unique Opportunity in Large B Cell Lymphoma (LBCL) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) ...

ALLO - Expected US Company Earnings on Monday, May 13th, 2024

Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...

ALLO - Notable earnings after Monday's close

2024-05-12 17:35:55 ET Major earnings expected after the bell on Monday include: Petróleo Brasileiro S.A. - Petrobras ( PBR ) Lithium Americas (Argentina) Corp. ( LAC ) StoneCo Ltd. ( STNE ) Inovio Pharmaceuticals ( INO ) Alcon ( ALC ) ...

ALLO - Allogene Therapeutics Q1 2024 Earnings Preview

2024-05-12 17:35:00 ET More on Allogene Therapeutics Allogene Therapeutics: 2024 Platform Vision Sings Mid-Term Upside Allogene Therapeutics, Inc. (ALLO) Q4 2023 Earnings Call Transcript Allogene Therapeutics GAAP EPS of -$0.51 misses by $0.06 Allogene Therap...

ALLO - 8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard

2024-05-12 11:22:00 ET This week, the healthcare sector saw 12 companies reporting their quarterly earnings, with 8 of them beating their bottom-line numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 8 out of 12 S&P 500 healthcar...

ALLO - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

ALLO - Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update

Conference Call and Webcast Scheduled for May 13, 2024 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR...

ALLO - Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more

2024-05-05 08:00:00 ET As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company ( NYSE: DIS ), Palantir Technologies ( NYSE: PLTR ), Realty Income ( NYSE: ...

Previous 10 Next 10